Cegedim Dendrite Gets Frost & Sullivan's IT Market Leadership Award
Oct 27, 2009 (Close-Up Media via COMTEX) --
Companies: Frost & Sullivan Inc (FRSU), World Life Sciences (WDLSF)
Cegedim Dendrite, a provider of Life Sciences-specific Customer Relationship Management (CRM) solutions, said the company has received Frost & Sullivan's 2009 World Life Sciences-IT Market Leadership Award.
In a release, the Company noted that Frost & Sullivan analysts determine the award winner through interviews with all market participants and extensive secondary research of proprietary data sources. Competitors are compared and ranked based on:
- Market share
- Revenue growth rates
- Profitability
- Market and technology innovation
"With increasing profitability, constant and increasing market share and technology innovation, Cegedim Dendrite has truly excelled above all comers in the industry," said Siddharth Saha, a Frost & Sullivan Industry Director. "An in-depth understanding of end-user requirements, robust research and development efforts and the ability to respond to end-user requirements have all contributed to an expanding customer base, making Cegedim Dendrite the forerunner in the pharmaceutical CRM market and a deserving recipient of the 2009 Frost & Sullivan Market Leadership Award."
Frost & Sullivan also recognized Cegedim Dendrite for its global reach with 40 offices supporting customers in more than 80 countries. According to Frost & Sullivan analysts, Cegedim Dendrite stood apart from the competition by leveraging its vast experience to assist the world's leading Life Sciences companies with the management and integration of information for optimal reduction in unessential spending. Furthermore, the company was lauded for its dedication to keeping abreast of market requirements by investing in its product portfolio.
"With this award, Frost & Sullivan confirmed that Cegedim Dendrite is achieving its vision of becoming the industry's leading global provider of innovative technology solutions in Life Sciences CRM solutions," said Laurent Labrune, Chief Executive Officer of Cegedim Dendrite. "We look forward to maintaining this position through continued product innovation designed to meet and exceed the current and future needs of our customers."
((Comments on this story may be sent to health@closeupmedia.com))
Copyright (C) 2009 Close-Up Media. All rights reserved
News Provided by COMTEX
Companies: Frost & Sullivan Inc (FRSU), World Life Sciences (WDLSF)
Related terms: ceo, crm, health, market, market share, rates, research, research and development, revenue, technology
